CEBPA Methylation as a Prognostic Biomarker in Adult Patients with De Novo AML.

被引：0
|
作者：
Chen, Hsin-Yu [1 ]
Lin, Tsung-Chin [1 ]
Chou, Wen-Chien [1 ]
Hou, Hsin-An [1 ]
Tien, Hwei-Fang [1 ]
Lin, Liang-In [1 ]
机构：
[1] Natl Taiwan Univ, Taipei 10764, Taiwan
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：628 / 628
页数：1
相关论文
共 50 条
  • [11] Cell cycle arrest and therapeutic sensitivity in de novo AML.
    Banker, D
    Willman, C
    Groudine, M
    Appelbaum, F
    BLOOD, 1997, 90 (10) : 290 - 290
  • [12] Prognostic significance of dysplastic hematopoiesis in patients with de novo AML
    Florschutz, A
    Kahl, C
    Borstel, A
    Grabenhorst, U
    Hoffkes, HG
    Franke, A
    BLOOD, 1996, 88 (10) : 313 - 313
  • [13] Karyotype and therapy-related acute myeloid leukemia (t-AML) both are independent prognostic parameters: An analysis of 93 patients with t-AML and 1091 patients with de novo AML.
    Schoch, C
    Kern, W
    Schnittger, S
    Dugas, M
    Sauerland, MC
    Heinecke, A
    Buechner, T
    Haferlach, T
    Hiddemann, W
    BLOOD, 2002, 100 (11) : 324A - 325A
  • [14] Atypical antigen expression on myeloblasts as a favorable prognostic factor in de novo adult AML
    Balana-Nowak, A.
    Zdzilowska, E.
    Skotnicki, A. B.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2007, 72B (02) : 147 - 148
  • [15] Cloretazine is an effective induction therapy in elderly patients (pts) with poor-risk de novo AML.
    Karp, J. E.
    Rizzieri, D.
    Vey, N.
    Mufti, G.
    Geller, R.
    O'Brien, S.
    Giles, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 340S - 340S
  • [16] Prognostic relevance of pretherapeutic in-vitro chemosensitivity testing in adult AML.
    Staib, P
    Lathan, B
    Michel, K
    Janz, E
    Schinkothe, T
    Diehl, V
    BLOOD, 1996, 88 (10) : 1447 - 1447
  • [17] Abnormal methylation status of the promoter of a PAF-1 in de novo AML patients
    Valencia, A.
    Cervera, J.
    Such, E.
    Garcia-Casado, Z.
    Pajuelo, J. C.
    Moscardo, F.
    Paciello, M. L.
    Scaff, M.
    Orti, G.
    Sanz-Santillana, G. F.
    Sanz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 393 - 393
  • [18] Influence of age on prognosis varies between distinct cytogenetic subgroups: A study on 1225 patients with de novo AML.
    Schoch, C
    Kern, W
    Schnittger, S
    Hiddemann, W
    Haferlach, T
    BLOOD, 2003, 102 (11) : 601A - 601A
  • [19] In-vitro drug resistance testing may provide an independent prognostic factor for adult patients with AML.
    Staib, P
    Schinköthe, T
    Henrichs, R
    Siebert, T
    Wiedenmann, S
    Schoch, C
    Voliotis, D
    Horn, PA
    Tesch, H
    Lathan, B
    Diehl, V
    BLOOD, 1999, 94 (10) : 63A - 63A
  • [20] A Measure of DNA Methylation for Predicting Outcome in De Novo AML
    Luskin, Marlise R.
    Gimotty, Phyllis A.
    Wertheim, Gerald
    Smith, Catherine
    Sehgal, Alison R.
    Luger, Selina M.
    Master, Stephen R.
    Loren, Alison W.
    Carroll, Martin P.
    BLOOD, 2014, 124 (21)
12345